Inhibitors of Bacillus subtilis DNA polymerase III. 6-(arylalkylamino)uracils and 6-anilinouracils
- PMID: 411934
- DOI: 10.1021/jm00219a015
Inhibitors of Bacillus subtilis DNA polymerase III. 6-(arylalkylamino)uracils and 6-anilinouracils
Abstract
6-(Benzylamino)uracils and substituted 6-anilinouracils have been found to be potent inhibitors of Bacillus subtilis DNA polymerase III by a mechanism identical with that of 6-(phenylhydrazino)uracils. Higher phenylalkylamino homologues are progressively weaker inhibitors of the enzyme. Examination of the effects of substituents on the activity of 6-(benzylamino)uracils against wild-type and mutant enzymes and preliminary results for 6-anilinouracils have permitted further dissection of the mechanism of inhibition. The experimental results indicate that (1) the polymerase inhibitor binding site is compact, accommodating only small alterations in the distance between the uracil and phenyl rings, (2) the phenyl ring, which provides the major contribution to inhibitor-enzyme binding, adopts a specific active conformation, and (3) an enzyme site which interacts with substituents in the phenyl ring forms a part of the active site of DNA polymerase III.
Similar articles
-
Inhibitors of Bacillus subtilis DNA polymerase III. 6-Anilinouracils and 6-(alkylamino)uracils.J Med Chem. 1980 Jan;23(1):34-8. doi: 10.1021/jm00175a007. J Med Chem. 1980. PMID: 6767030
-
Inhibitors of Bacillus subtilis DNA polymerase III. Structure-activity relationships of 6-(phenylhydrazino)uracils.J Med Chem. 1977 Sep;20(9):1181-5. doi: 10.1021/jm00219a014. J Med Chem. 1977. PMID: 411933
-
Quantitative structure-activity relationships of 6-anilinouracils as inhibitors of Bacillus subtilis DNA polymerase III.J Med Chem. 1984 Feb;27(2):181-5. doi: 10.1021/jm00368a013. J Med Chem. 1984. PMID: 6420570
-
Discovery and development of DNA polymerase IIIC inhibitors to treat Gram-positive infections.Bioorg Med Chem. 2019 Aug 1;27(15):3209-3217. doi: 10.1016/j.bmc.2019.06.017. Epub 2019 Jun 11. Bioorg Med Chem. 2019. PMID: 31221610 Review.
-
In search of uracil derivatives as bioactive agents. Uracils and fused uracils: Synthesis, biological activity and applications.Eur J Med Chem. 2015 Jun 5;97:582-611. doi: 10.1016/j.ejmech.2014.10.008. Epub 2014 Oct 5. Eur J Med Chem. 2015. PMID: 25306174 Review.
Cited by
-
In silico screening for novel inhibitors of DNA polymerase III alpha subunit of Mycobacterium tuberculosis (MtbDnaE2, H37Rv).PLoS One. 2015 Mar 26;10(3):e0119760. doi: 10.1371/journal.pone.0119760. eCollection 2015. PLoS One. 2015. PMID: 25811866 Free PMC article.
-
Glymes as Versatile Solvents for Chemical Reactions and Processes: from the Laboratory to Industry.RSC Adv. 2014;4(22):11251-11287. doi: 10.1039/C3RA47191H. RSC Adv. 2014. PMID: 24729866 Free PMC article.
-
Low frequencies of resistance among Staphylococcus and Enterococcus species to the bactericidal DNA polymerase inhibitor N(3)-hydroxybutyl 6-(3'-ethyl-4'-methylanilino) uracil.Antimicrob Agents Chemother. 2002 Dec;46(12):3770-5. doi: 10.1128/AAC.46.12.3770-3775.2002. Antimicrob Agents Chemother. 2002. PMID: 12435675 Free PMC article.
-
Design and characterization of N2-arylaminopurines which selectively inhibit replicative DNA synthesis and replication-specific DNA polymerases: guanine derivatives active on mammalian DNA polymerase alpha and bacterial DNA polymerase III.Nucleic Acids Res. 1982 Jul 24;10(14):4431-40. doi: 10.1093/nar/10.14.4431. Nucleic Acids Res. 1982. PMID: 6812026 Free PMC article.
-
Butylanilinouracil: a selective inhibitor of HeLa cell DNA synthesis and HeLa cell DNA polymerase alpha.Nucleic Acids Res. 1980 Jan 11;8(1):99-109. doi: 10.1093/nar/8.1.99. Nucleic Acids Res. 1980. PMID: 6153466 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources